Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where PacBio is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- S-82026-08-07Employee stock plan
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-05Current report (material event)
- 8-K2026-07-09Current report (material event)
- 8-K2026-06-04Current report (material event)
- SD2026-05-27SD
- DEFA14A2026-05-22DEFA14A
- 10-Q2026-05-08Quarterly report
- 8-K2026-05-07Current report (material event)
- ARS2026-04-23Annual report to holders
- DEFA14A2026-04-23DEFA14A
- DEF 14A2026-04-23Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-06Current report (material event)
- 8-K2026-03-05Current report (material event)
- S-3ASR2026-02-25S-3ASR
- S-82026-02-25Employee stock plan
- 10-K2026-02-25Annual report
- 8-K2026-02-12Current report (material event)
- 8-K2026-02-03Current report (material event)
- SCHEDULE 13G/A2026-02-03SCHEDULE 13G/A
- 8-K2026-02-02Current report (material event)
- 8-K2026-01-12Current report (material event)
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-05Current report (material event)
- SCHEDULE 13G/A2025-11-04SCHEDULE 13G/A
- SCHEDULE 13G/A2025-08-13SCHEDULE 13G/A
- S-82025-08-07Employee stock plan
- 10-Q2025-08-07Quarterly report
- 8-K2025-08-07Current report (material event)
- SCHEDULE 13G/A2025-07-24SCHEDULE 13G/A
- 8-K2025-06-06Current report (material event)
- SD2025-05-29SD
- DEFA14A2025-05-20DEFA14A
- 10-Q2025-05-12Quarterly report
- 8-K2025-05-08Current report (material event)
- SCHEDULE 13G/A2025-04-30SCHEDULE 13G/A
- ARS2025-04-23Annual report to holders
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.